Valuation: Iqvia Holdings Inc.

Capitalization 29.29B 25.25B 22.8B 21.87B 39.89B 2,692B 41.75B 270B 108B 1,291B 110B 108B 4,617B P/E ratio 2026 *
21.2x
P/E ratio 2027 * 17.8x
Enterprise value 42.37B 36.53B 32.98B 31.64B 57.7B 3,894B 60.38B 390B 156B 1,867B 159B 156B 6,678B EV / Sales 2026 *
2.46x
EV / Sales 2027 * 2.27x
Free-Float
67.55%
Yield 2026 *
-
Yield 2027 * -
1 day-2.25%
1 week-2.42%
Current month-2.42%
1 month-6.93%
3 months-22.74%
6 months-7.03%
Current year-22.59%
1 week 168.53
Extreme 168.53
182.93
1 month 156.66
Extreme 156.665
194.83
Current year 156.66
Extreme 156.665
247.04
1 year 134.64
Extreme 134.645
247.04
3 years 134.64
Extreme 134.645
261.73
5 years 134.64
Extreme 134.645
285.61
10 years 61.21
Extreme 61.21
285.61
Manager TitleAgeSince
Chief Executive Officer 65 02/10/2016
Director of Finance/CFO 65 31/07/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 68 04/02/2015
Director/Board Member 60 31/12/2007
Chairman 65 02/10/2016
Change 5d. change 1-year change 3-years change Capi.($)
-2.25%-2.42%-5.92%-20.53% 29.29B
-2.02%-5.97%-11.64%-10.60% 45.49B
+2.79%-5.01%+17.18%+26.18% 33.41B
+0.47%-10.90%+17.49%+52.87% 31.32B
-1.24%-3.55%+150.89%+294.55% 19.5B
+1.39%+3.06%+58.83%+111.91% 14.77B
+0.26%+4.17%+44.47%+134.63% 13.36B
-1.64%-5.25%+24.86%+3.99% 13.22B
-1.49%-8.76%+115.30%+104.25% 12.23B
-3.55%-10.98%+20,917.10%+3,285.53% 11.55B
Average -0.73%-4.42%+2,132.86%+398.28% 22.41B
Weighted average by Cap. -0.58%-4.92%+1,106.84%+222.66%

Financials

2026 *2027 *
Net sales 17.24B 14.87B 13.42B 12.88B 23.48B 1,584B 24.57B 159B 63.55B 760B 64.71B 63.33B 2,717B 18.25B 15.74B 14.2B 13.63B 24.85B 1,677B 26.01B 168B 67.27B 804B 68.49B 67.03B 2,877B
Net income 1.45B 1.25B 1.13B 1.08B 1.97B 133B 2.07B 13.33B 5.34B 63.86B 5.44B 5.32B 228B 1.68B 1.45B 1.31B 1.25B 2.29B 154B 2.39B 15.45B 6.19B 74.02B 6.3B 6.17B 265B
Net Debt 13.08B 11.27B 10.18B 9.77B 17.81B 1,202B 18.64B 120B 48.2B 576B 49.08B 48.03B 2,061B 12.23B 10.54B 9.52B 9.13B 16.65B 1,124B 17.42B 112B 45.07B 539B 45.89B 44.91B 1,927B
Logo Iqvia Holdings Inc.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (40.6%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (4.9%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (47.5%), Europe and Africa (31.8%) and Asia/Pacific (20.7%).
Employees
93,000
Date Price Change Volume
06/03/26 174.49 $ -2.25% 1,766,022
05/03/26 178.50 $ +0.35% 2,101,693
04/03/26 177.88 $ +2.25% 1,778,975
03/03/26 173.96 $ -0.18% 1,577,293
02/03/26 174.27 $ -2.54% 1,807,322
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
174.49USD
Average target price
235.52USD
Spread / Average Target
+34.98%

Quarterly revenue - Rate of surprise